{"disease":{"id":"hepatitis-delta-virus","name":"hepatitis delta virus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03719313","title":"Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":407,"lead_sponsor_name":"Eiger BioPharmaceuticals","has_results":false},{"nct_id":"NCT05070364","title":"Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Eiger BioPharmaceuticals","has_results":false},{"nct_id":"NCT05861674","title":"A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT06740474","title":"A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Assembly Biosciences","has_results":false},{"nct_id":"NCT06780579","title":"Expanded Access for Bulevirtide","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Gilead Sciences","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}